NEW YORK, Nov. 4 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. today announced that Ron Bentsur, the Company’s Chief Executive Officer, is scheduled to present at the Merriman Curhan Ford 6th Annual Investor Summit being held in New York City.
About Keryx Biopharmaceuticals, Inc.
CONTACT: Lauren Fischer, Director, Investor Relations, Keryx
Biopharmaceuticals, Inc., +1-212-531-5962, lfischer@keryx.com
Web site: http://investors.keryx.com/
